Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Consult Clin Psychol. 2016 Jan 4;84(4):353–364. doi: 10.1037/ccp0000071

Table 2.

Characteristics of the CT Patient Sample per Personality Disorder Co-morbidity

No PD (n=33) PD (n=26)
Age 42.4 (13.1) 37.3 (8.7)
Gender (% Female) 66.7% 46.2%
Caucasian (% Yes) 78.8% 76.9%
Unemployed 15.1% 30.8%
Years of Education 14.5 (2.8) 14.5 (2.1)
IQ 109.3 (13.1) 109.8 (9.1)
Intake BDI-II 30.8 (9.3) 31.1 (8.0)
Intake HRSD 23.4 (2.5) 25.9 (4.2)
BDI-II at Session 3 22.2 (9.7) 27.4 (10.3)
BDI-II Change Prior to Session 3 8.5 (11.1) 3.7 (8.0)
Total BDI-II Change 20.6 (11.3) 14.5 (12.5)
Age at Depression Onset*** 28.8 (13.5) 17.9 (9.3)
Number of Prior Episodes*** 1.6 (1.4) 3.3 (2.3)
Number of Prior Treatments 1.6 (1.7) 1.9 (2.0)
Chronic Depression (% Yes) 36.4% 53.8%
Recurrent Depression (% Yes) 69.7% 84.6%
Dysthymia (% Yes) 24.2% 23.1%
Intake HRSA 17.9 (7.5) 15.5 (5.8)
Intake Beck Hopelessness Scale 10.2 (5.3) 12.6 (4.9)
Intake Dysfunctional Attitudes Scale* 134.4 (35.5) 158.6 (33.9)
Session 3 CT-Concrete 22.5 (6.2) 20.7 (5.6)
Session 3 CT-Belief 2.2 (2.0) 2.5 (2.2)

Note. BDI-II = Beck Depression Inventory-II; HRSA = Hamilton Rating Scale for Anxiety; HRSD = Hamilton Rating Scale for Depression; All values reported as the group mean (standard deviation); All binary variables tested with an exact χ2 test

p <.10;

*

p <.05;

***

p <.001